Company intelligence
28bio
Predict neurological response with human CNS & PNS organoids.
About 28bio
28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today’s neurological health crisis by improving the ability to predict which therapies will work in humans. 28bio is committed to advancing ethical standards in the development of brain organoid technology and engineered human cognition. For more information, visit 28bio.com. Our name is a tribute to the 28 crew members of Shackleton’s Endurance expedition and what’s possible when we forge ahead with an unbreakable will to explore and understand the unknown.
Verified activity
Signals from 28bio
2 published signals
Presence & Recognition
28bio is presenting on the CNS and PNS product portfolio at the International MPS Society webinar taking place today
Reported by 28bio
Presence & Recognition
28bio will not have a booth at the EUROTOX Congress 2026, but SVP of Sales Nicholas Ayers will be onsite September 13–16.
Reported by 28bio